Skip to content
10-Q

Quarterly Report

Surgery Partners, Inc. SGRY

0001638833-25-000163

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 129.34M sh
Shares Diluted Q3 2025 · Sep 30, 2025 127.21M sh
Shares Diluted Q3 2025 · Sep 30, 2025 126.93M sh
Shares Diluted Q3 2025 · Sep 30, 2024 126.17M sh
Shares Diluted Q3 2025 · Sep 30, 2024 126.09M sh
Capex Q3 2025 · Sep 30, 2025 $65.9M
Capex Q3 2025 · Sep 30, 2024 $68.1M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $170.9M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $188.7M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $203.4M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $269.5M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.73B
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.79B
Current Liabilities Q3 2025 · Sep 30, 2025 $586M
Current Liabilities Q3 2025 · Dec 31, 2024 $624.4M
Current Assets Q3 2025 · Sep 30, 2025 $1.1B
Current Assets Q3 2025 · Dec 31, 2024 $1.12B
Total Assets Q3 2025 · Sep 30, 2025 $7.95B
Total Assets Q3 2025 · Dec 31, 2024 $7.89B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.18
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.50
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.25
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.47
Eps Basic Q3 2025 · Sep 30, 2025 −$0.18
Eps Basic Q3 2025 · Sep 30, 2025 −$0.50
Eps Basic Q3 2025 · Sep 30, 2024 −$0.25
Eps Basic Q3 2025 · Sep 30, 2024 −$0.47
Sga Expense Q3 2025 · Sep 30, 2025 $22.4M
Sga Expense Q3 2025 · Sep 30, 2025 $94.5M
Sga Expense Q3 2025 · Sep 30, 2024 $29.2M
Sga Expense Q3 2025 · Sep 30, 2024 $102.7M
Net Income Q3 2025 · Sep 30, 2025 −$22.7M
Net Income Q3 2025 · Sep 30, 2025 −$62.9M
Net Income Q3 2025 · Sep 30, 2024 −$31.7M
Net Income Q3 2025 · Sep 30, 2024 −$59.6M
Operating Income Q3 2025 · Sep 30, 2025 $105.7M
Operating Income Q3 2025 · Sep 30, 2025 $279.3M
Operating Income Q3 2025 · Sep 30, 2024 $60.9M
Operating Income Q3 2025 · Sep 30, 2024 $221.7M